Insiders Updates
Investing in TherapeuticsMD Inc (TXMD): What You Must Know
TherapeuticsMD Inc’s recent filing unveils that its Director Collins Cooper C. acquired Company’s shares for reported $7099.0 on Aug 22
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.